Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted January 30, 2018
Limbrel for Osteoarthritis Recalled Due to Risk of Adverse Effects
On January 26, 2018, Primus Pharmaceuticals, Inc. of Scottsdale, Arizona issued a recall of all unexpired lots of Limbrel products. FDA requested the recall due to rare but serious side effects (which are reversible), including drug-induced liver injury and/or hypersensitivity pneumonitis, associated with the use of Limbrel.